Literature DB >> 22346299

Influenza update: a review of currently available vaccines.

Lisa R Clayville.   

Abstract

Year:  2011        PMID： 22346299      PMCID： PMC3278149     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


× No keyword cloud information.
  47 in total

1.  Immunogenicity, large scale safety and lot consistency of an intradermal influenza vaccine in adults aged 18-60 years: Randomized, controlled, phase III trial.

Authors:  Robert Arnou; Patrick Eavis; José-Ramon De Juanes Pardo; Arvydas Ambrozaitis; Marie-Pierre Kazek; Françoise Weber
Journal:  Hum Vaccin       Date:  2010-04-15

2.  Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects.

Authors:  Robert B Couch; Patricia Winokur; Rebecca Brady; Robert Belshe; Wilbur H Chen; Thomas R Cate; Bryndis Sigurdardottir; Amy Hoeper; Irene L Graham; Robert Edelman; Fenhua He; Diane Nino; Jose Capellan; Frederick L Ruben
Journal:  Vaccine       Date:  2007-09-14       Impact factor: 3.641

3.  Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial.

Authors:  David Holland; Robert Booy; Ferdinandus De Looze; Peter Eizenberg; James McDonald; Jeff Karrasch; Maureen McKeirnan; Hatem Salem; Graham Mills; Jim Reid; Françoise Weber; Melanie Saville
Journal:  J Infect Dis       Date:  2008-09-01       Impact factor: 5.226

4.  Better influenza vaccines for older people: what will it take?

Authors:  Janet E McElhaney; Jan P Dutz
Journal:  J Infect Dis       Date:  2008-09-01       Impact factor: 5.226

5.  Seasonal influenza vaccine delivered by intradermal microinjection: A randomised controlled safety and immunogenicity trial in adults.

Authors:  Isabel Leroux-Roels; Eva Vets; Ralf Freese; Michael Seiberling; Françoise Weber; Camille Salamand; Geert Leroux-Roels
Journal:  Vaccine       Date:  2008-12-02       Impact factor: 3.641

6.  The impact of influenza and influenza-like illness on productivity and healthcare resource utilization in a working population.

Authors:  M Keech; A J Scott; P J Ryan
Journal:  Occup Med (Lond)       Date:  1998-02       Impact factor: 1.611

Review 7.  Measuring protection: efficacy versus effectiveness.

Authors:  D S Fedson
Journal:  Dev Biol Stand       Date:  1998

Review 8.  Immunity to influenza in man.

Authors:  R B Couch; J A Kasel
Journal:  Annu Rev Microbiol       Date:  1983       Impact factor: 15.500

9.  Field trial with human and equine influenza vaccines in children: protection and antibody titres.

Authors:  A Wesselius-de Casparis; N Masurel; K F Kerrebijn
Journal:  Bull World Health Organ       Date:  1972       Impact factor: 9.408

10.  Influenza-associated hospitalizations in the United States.

Authors:  William W Thompson; David K Shay; Eric Weintraub; Lynnette Brammer; Carolyn B Bridges; Nancy J Cox; Keiji Fukuda
Journal:  JAMA       Date:  2004-09-15       Impact factor: 56.272
View more
  16 in total

Review 1.  Fluzone® intra-dermal (Intanza®/Istivac® Intra-dermal): An updated overview.

Authors:  Nicola Luigi Bragazzi; Andrea Orsi; Filippo Ansaldi; Roberto Gasparini; Giancarlo Icardi
Journal:  Hum Vaccin Immunother       Date:  2016-05-31       Impact factor: 3.452

2.  NetworkSIR and EnvironmentalSIR: Effective, Open-Source Epidemic Modeling in the Absence of Data.

Authors:  Madison A Pickering; Subbarayan Venkatesan; Christoph U Lehmann; Sameh Saleh; Richard J Medford
Journal:  AMIA Annu Symp Proc       Date:  2022-02-21

3.  Epipharyngeal Abrasive Therapy Down-regulates the Expression of Cav1.2: A Key Molecule in Influenza Virus Entry.

Authors:  Kensuke Nishi; Shohei Yoshimoto; Soichiro Nishi; Tatsuro Nishi; Ryushiro Nishi; Toshiyuki Tsunoda; Hiromitsu Morita; Hiroaki Tanaka; Osamu Hotta; Susumu Yasumasu; Kenji Hiromatsu; Senji Shirasawa; Takashi Nakagawa; Takafumi Yamano
Journal:  In Vivo       Date:  2022 Sep-Oct       Impact factor: 2.406

4.  Broccoli Leaves Attenuate Influenza A Virus Infection by Interfering With Hemagglutinin and Inhibiting Viral Attachment.

Authors:  Won-Kyung Cho; Nam-Hui Yim; Myong-Min Lee; Chang-Hoon Han; Jin Yeul Ma
Journal:  Front Pharmacol       Date:  2022-06-30       Impact factor: 5.988

5.  Social media effectiveness as a humanitarian response to mitigate influenza epidemic and COVID-19 pandemic.

Authors:  Sameer Kumar; Chong Xu; Nidhi Ghildayal; Charu Chandra; Muer Yang
Journal:  Ann Oper Res       Date:  2021-01-29       Impact factor: 4.820

6.  Interplay between hypoxia and inflammation contributes to the progression and severity of respiratory viral diseases.

Authors:  Sulagna Bhattacharya; Sakshi Agarwal; Nishith M Shrimali; Prasenjit Guchhait
Journal:  Mol Aspects Med       Date:  2021-07-19

Review 7.  Advances and future challenges in recombinant adenoviral vectored H5N1 influenza vaccines.

Authors:  Jianfeng Zhang
Journal:  Viruses       Date:  2012-11-01       Impact factor: 5.048

8.  Influenza-Induced Oxidative Stress Sensitizes Lung Cells to Bacterial-Toxin-Mediated Necroptosis.

Authors:  Norberto Gonzalez-Juarbe; Ashleigh N Riegler; Alexander S Jureka; Ryan P Gilley; Jeffrey D Brand; John E Trombley; Ninecia R Scott; Maryann P Platt; Peter H Dube; Chad M Petit; Kevin S Harrod; Carlos J Orihuela
Journal:  Cell Rep       Date:  2020-08-25       Impact factor: 9.995

9.  COVID-19 and rationally layered social distancing.

Authors:  Richard A Stein
Journal:  Int J Clin Pract       Date:  2020-04-06       Impact factor: 3.149

Review 10.  Dangerous Pathogens as a Potential Problem for Public Health.

Authors:  Edyta Janik; Michal Ceremuga; Marcin Niemcewicz; Michal Bijak
Journal:  Medicina (Kaunas)       Date:  2020-11-06       Impact factor: 2.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.